Hôpital Européen Georges Pompidou - AP-HP

56 currently recruiting clinical trials
Create patient profile for matching
Phase 3 Endometrial cancer #NCT06712472 #2023-503886-44-00
Required histologic sub types
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Carcinosarcoma
Required FIGO stages
Stage I Stage II Stage III
Required disease stage
Localized Locally Advanced
Required genetic anomalies
TP53
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Surgery Chemotherapy Radiotherapy
Excluded genetic anomalies
MSI/dMMR POLE
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Prostate cancer #NCT06136624 #2023-504899-25-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Metastatic Castration-resistant
Required number of previous lines of therapy for current stage of disease
1 2 3 or more
Required previous treatments at advanced or metastatic stage
Chemotherapy Hormone therapy
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Merck Sharp & Dohme LLC
Phase 3 Colon cancer #NCT05855200 #2023-503265-27-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Localized Locally Advanced
Required genetic anomalies
MSI/dMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
MSS/pMMR
Hôpital Européen Georges Pompidou - AP-HP (Paris)
GlaxoSmithKline
Phase 3 Colon cancer Rectal cancer #NCT06293625
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Required genetic anomalies
MSS/pMMR
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Excluded genetic anomalies
MSI/dMMR
Hôpital Européen Georges Pompidou - AP-HP (Paris)
CHU Dijon
Phase 3 Prostate cancer #NCT04916613 #2022-502425-18-00
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
UNICANCER
Phase 3 Kidney cancer #NCT06364631 #2023-503317-29-00
Required histologic types
Clear cell carcinoma
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required IMDC scores
0 1 or 2
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Prostate cancer #NCT05974774 #2023-506817-23-01
Required disease stage
Metastatic Hormone-sensitive
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Hormone therapy
Hôpital Européen Georges Pompidou - AP-HP (Paris)
EORTC - Organisation Européenne pour la Recherche et le Traitement du Cancer
Phase 3 Colon cancer Rectal cancer #NCT05253651 #2024-514180-25-00
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced Metastatic
Required genetic anomalies
HER2
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded genetic anomalies
KRAS G12C KRAS non G12C NRAS
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Seagen
Phase 3 Lung cancer #NCT04339218
Required histologic types
NSCLC (Non-Small Cell Lung Cancer)
Required histologic sub types
Non-squamous NSCLC
Required disease stage
Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Institut Bergonié
Phase 2 / Phase 3 Bladder / Urinary Tract / Urethral cancer #NCT07129993 #2024-516906-47-00
Required histologic types
Invasive bladder cancer Upper excretory tract cancer Urethral cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
1
Required previous treatments at advanced or metastatic stage
Immunotherapy Antibody Drug Conjugates (ADC)
Excluded previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Européen Georges Pompidou - AP-HP (Paris)
Daiichi Sankyo